Generic Name

Ioflupane I-123

Brand Names
DaTscan, Ioflupane
FDA approval date: March 01, 2011
Classification: Radioactive Diagnostic Agent
Form: Injection

What is DaTscan (Ioflupane I-123)?

DATSCAN is indicated as an adjunct to other diagnostic evaluations for striatal dopamine transporter visualization using single photon emission computed tomography brain imaging in adult patients with: suspected Parkinsonian syndromes or suspected dementia with Lewy bodies . DATSCAN is a radioactive diagnostic agent indicated as an adjunct to other diagnostic evaluations for striatal dopamine transporter visualization using single photon emission computed tomography brain imaging in adult patients with: suspected Parkinsonian syndromes or suspected dementia with Lewy bodies .
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms

Related Clinical Trials

The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

Summary: The purpose of this study is to identify and distinguish two different types of Progressive Apraxia of Speech through clinical imaging and testing.

Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

Summary: Background and Rationale Essential tremor (ET) affects over 6 million Americans and approximately 5% of adults over age 60. Patients with ET have a 10-20 times higher risk of developing Parkinson's disease (PD) compared to age-matched populations, with approximately 1% converting to PD annually. Post-mortem studies reveal Lewy body pathology in some ET patients, suggesting a subset may have prodro...

Video-oculography and Parkinson's Disease: A Prospective Study

Summary: This study aims to study, in patient with Parkinson's disease, mild to moderate stage (according to Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's Disease, Postuma et al., 2015): * the evolution of oculomotricity markers over time. * the correlation between neurological evaluations (motor and non-motor scores), neuropsychological evaluations (cognitive disorders) and oculom...

Brand Information